Proactive Investors - Run By Investors For Investors

Amryt Pharma agrees Lojuxta distribution deal for Romania and Bulgaria

Dave Allmond, chief commercial officer at Amryt Pharma PLC (LON:AMYT), discusses with Proactive their fourth distribution deal signed in three months for Lojuxta.

Lojuxta treats a very rare, life-threatening genetic condition which causes “bad cholesterol” to accumulate in the body. 

This latest agreement, covering Romania and Bulgaria, is with Romastru Trading, part of the Pharaon Healthcare Europe conglomerate.

 
Meet Metro Mining Ltd and Elementos Ltd at our event, Melbourne , 10 April 2019. Register here »
View full AMYT profile View Profile

Amryt Pharma PLC Timeline

© Proactive Investors 2019

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use